Earnings Feed
Start Free
Aligos Therapeutics, Inc.·4

Oct 27, 4:14 PM ET

BLATT LAWRENCE 4

4 · Aligos Therapeutics, Inc. · Filed Oct 27, 2023

Insider Transaction Report

Form 4
Period: 2023-10-25
Aligos Therapeutics, Inc.ALGS
BLATT LAWRENCE
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2023-10-25$0.76/sh+610,277$461,858→ 1,847,575 total
  • Award

    Warrants (Right to Buy)

    2023-10-25$0.13/sh+305,138$38,142→ 305,138 total
    Exercise: $0.76From: 2023-10-25Exp: 2030-10-25→ Common Stock (305,138 underlying)
Holdings

  • Common Stock

    (indirect: See footnote)
    113,423

  • Common Stock

    (indirect: See footnote)
    122,601

  • Common Stock

    (indirect: See footnote)
    18,517

  • Common Stock

    (indirect: See footnote)
    18,517
Footnotes (4)
  • [F1]Lawrence M. Blatt Living Trust dated 8/27/14.
  • [F2]PENSCO Trust Company LLC Custodian FBO Dr. Lawrence Blatt IRA.
  • [F3]Zachary David Blatt Irrevocable Trust dated 8/24/14.
  • [F4]Zoe Anne Blatt Irrevocable Trust dated 8/24/14.

Documents

1 file
  • 4
    form4.xmlPrimary